A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This four-period, single-center, open-label, single-dose, randomized, cross-over study will
assess the bioequivalence and safety of an oral solution of Copegus (ribavirin) compared to a
Copegus tablet in healthy adult volunteers. Volunteers will be randomized to one of four
sequences in which they will receive the treatment under fed and under fasted conditions.